Ö. Ö. Isiklar Et Al. , "Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?," CLINICAL BIOCHEMISTRY , vol.45, no.16-17, pp.1325-1330, 2012
Isiklar, Ö. Ö. Et Al. 2012. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?. CLINICAL BIOCHEMISTRY , vol.45, no.16-17 , 1325-1330.
Isiklar, Ö. Ö., BARUTÇUOĞLU, B., Kabaroglu, C., Mutaf, I., Ozmen, D., Bayindir, O., ... ZOGHİ, M.(2012). Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?. CLINICAL BIOCHEMISTRY , vol.45, no.16-17, 1325-1330.
Isiklar, ÖZBEN Et Al. "Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?," CLINICAL BIOCHEMISTRY , vol.45, no.16-17, 1325-1330, 2012
Isiklar, ÖZBEN Ö. Et Al. "Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?." CLINICAL BIOCHEMISTRY , vol.45, no.16-17, pp.1325-1330, 2012
Isiklar, Ö. Ö. Et Al. (2012) . "Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?." CLINICAL BIOCHEMISTRY , vol.45, no.16-17, pp.1325-1330.
@article{article, author={ÖZBEN ÖZDEN IŞIKLAR Et Al. }, title={Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?}, journal={CLINICAL BIOCHEMISTRY}, year=2012, pages={1325-1330} }